Longevity Health Holdings, Inc. Gain (Loss) on Derivative Instruments, Net, Pretax
Longevity Health Holdings, Inc. (XAGE) reported Gain (Loss) on Derivative Instruments, Net, Pretax of $826.98 thousand for the 12-month period ending 2023-12-31, per its 10-K/A filed 2025-06-17.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2025-06-17
- Longevity Health Holdings, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2023-12-31 was $0.00.
- Longevity Health Holdings, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2023-09-30 was $4.70M.
- Longevity Health Holdings, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2023-06-30 was -$3.55M.
- Longevity Health Holdings, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2023-03-31 was -$325.08K.
- Longevity Health Holdings, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2023 was $826.98K, a 34.33% decline from fiscal 2022.
- Longevity Health Holdings, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2022 was $1.26M.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-06-17 | $4.70M derived: sum of 2 quarters · filed 2025-06-17 | $1.15M derived: sum of 3 quarters · filed 2025-06-17 | $826.98K 10-K/A · filed 2025-06-17 |
| 2023-09-30 | $4.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.15M derived: sum of 2 quarters · filed 2024-11-14 | $826.98K 10-Q · filed 2024-11-14 | $826.98K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$3.87M 10-Q · filed 2024-08-14 | -$3.87M derived: sum of 3 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$325.08K 10-Q · filed 2024-05-15 | -$325.08K derived: sum of 2 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.26M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $1.26M 10-Q · filed 2023-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |